154 related articles for article (PubMed ID: 6150904)
1. Neurochemical psychiatry as a source of hypotheses concerning the role of homeostatic mechanisms in brain function.
Richardson JS
Int J Neurosci; 1984 Nov; 24(3-4):197-202. PubMed ID: 6150904
[TBL] [Abstract][Full Text] [Related]
2. [Neurotransmitters and psychoses: the monamine hypotheses].
Felix D
Schweiz Arch Neurol Psychiatr (1985); 1986; 137(5):15-23. PubMed ID: 2431467
[No Abstract] [Full Text] [Related]
3. Neurochemical and neuroendocrine dysregulation in affective disorders.
Golden RN; Potter WZ
Psychiatr Clin North Am; 1986 Jun; 9(2):313-27. PubMed ID: 2873561
[TBL] [Abstract][Full Text] [Related]
4. Neurotransmitter specific alterations in dementing disorders: insights from animal models.
Coyle JT; Singer H; McKinney M; Price D
J Psychiatr Res; 1984; 18(4):501-12. PubMed ID: 6150995
[TBL] [Abstract][Full Text] [Related]
5. Synaptopathic mechanisms of neurodegeneration and dementia: Insights from Huntington's disease.
Tyebji S; Hannan AJ
Prog Neurobiol; 2017 Jun; 153():18-45. PubMed ID: 28377290
[TBL] [Abstract][Full Text] [Related]
6. Modeling dopamine system dysfunction in experimental animals.
Hantraye P
Nucl Med Biol; 1998 Nov; 25(8):721-8. PubMed ID: 9863556
[TBL] [Abstract][Full Text] [Related]
7. Animal models of depression: parallels and correlates to severe depression in humans.
Jesberger JA; Richardson JS
Biol Psychiatry; 1985 Jul; 20(7):764-84. PubMed ID: 2860930
[TBL] [Abstract][Full Text] [Related]
8. Neurotransmitters and psychosis.
Owen F; Crow TJ
Br Med Bull; 1987 Jul; 43(3):651-71. PubMed ID: 2892562
[No Abstract] [Full Text] [Related]
9. [Locus coeruleus: implications for psychiatry].
Orellana Vidal GP
Acta Psiquiatr Psicol Am Lat; 1995 Mar; 41(1):57-66. PubMed ID: 7660848
[TBL] [Abstract][Full Text] [Related]
10. Hypothesized neurochemical models for psychiatric syndromes in alcohol and drug dependence.
Extein IL; Gold MS
J Addict Dis; 1993; 12(3):29-43. PubMed ID: 7504527
[TBL] [Abstract][Full Text] [Related]
11. Neuropeptides in dopamine-containing regions of the brain.
Albanese A; Altavista MC
Ital J Neurol Sci; 1984 Dec; 5(4):391-404. PubMed ID: 6152262
[TBL] [Abstract][Full Text] [Related]
12. [Dopamine: not just a neurotransmitter].
Drozak J; Bryła J
Postepy Hig Med Dosw (Online); 2005; 59():405-20. PubMed ID: 16106242
[TBL] [Abstract][Full Text] [Related]
13. Psychotherapeutic drugs and biogenic amines. Current concepts and therapeutic implications.
Potter WZ
Drugs; 1984 Aug; 28(2):127-43. PubMed ID: 6205841
[TBL] [Abstract][Full Text] [Related]
14. The dopamine system and the pathophysiology of schizophrenia: a basic science perspective.
Goto Y; Grace AA
Int Rev Neurobiol; 2007; 78():41-68. PubMed ID: 17349857
[TBL] [Abstract][Full Text] [Related]
15. Magnetic resonance spectroscopy and its applications in psychiatry.
Malhi GS; Valenzuela M; Wen W; Sachdev P
Aust N Z J Psychiatry; 2002 Feb; 36(1):31-43. PubMed ID: 11929436
[TBL] [Abstract][Full Text] [Related]
16. Chemical transmitter systems in the brain.
Shute CC
Mod Trends Neurol; 1975; 6():183-203. PubMed ID: 607
[No Abstract] [Full Text] [Related]
17. Adenosine receptors and brain diseases: neuroprotection and neurodegeneration.
Gomes CV; Kaster MP; Tomé AR; Agostinho PM; Cunha RA
Biochim Biophys Acta; 2011 May; 1808(5):1380-99. PubMed ID: 21145878
[TBL] [Abstract][Full Text] [Related]
18. Pleiotropic effects of neurotransmission during development: modulators of modularity.
Thompson BL; Stanwood GD
J Autism Dev Disord; 2009 Feb; 39(2):260-8. PubMed ID: 18648918
[TBL] [Abstract][Full Text] [Related]
19. [Current status of biochemical hypotheses in the pathogenesis of schizophrenia].
Kornhuber J; Weller M
Nervenarzt; 1994 Nov; 65(11):741-54. PubMed ID: 7816150
[TBL] [Abstract][Full Text] [Related]
20. Neurotransmitter interactions related to central dopamine neurons.
Lloyd KG
Essays Neurochem Neuropharmacol; 1978; 3():129-207. PubMed ID: 30628
[No Abstract] [Full Text] [Related]
[Next] [New Search]
